S1533002
Co-Amoxiclav 125mg+ 31.25mg BOT/100ml
Amoxicillin 125mg + Clavulanic Acid 31.25mg per 5ml powder for oral suspension (Co-Amoxiclav), bottle of 100 ml. A suitable dose measuring device is included.
Indicative Price 3.15 USD
General description:
Amoxicillin 125mg/5ml and Clavulanic Acid 31.25 mg/5ml powder for oral suspension
(Co-amoxiclav), bottle of 100 ml. A suitable measuring device will be included.
Technical specifications:
The powder for oral suspension should contain Amoxicillin Trihydrate equivalent to 125 mg/5ml Amoxicillin and Potassium Clavulanate equivalent to 31.25 mg/5 ml Clavulanic acid, bottle of 100ml.
Therapeutic class:
Amoxicillin is a Beta-Lactam antibiotic.
Clavulanic acid is a Beta-Lactamase inhibitor.
Indications:
Treatment of bacterial infections susceptible to Amoxicillin and Clavulanate Potassium either alone or in combination with other antibiotics.
Dosage, Instructions for use
Refer to the guidelines below:
WHO Model Formulary 2008
WHO Model Formulary for Children 2010
WHO Packet book for hospital care for Children 2013
Shelf life:
36 months.
Storage and transportation
This product must be transported between +15° C to +25° C
Product attributes
 | Component of kits |
|---|---|
 | Shelf life |
 | Storage consideration |
 | Temperature considerations |
 | Warehouse Item |
| To see icon descriptions, go to ' Product attribute guide' |
Related Products